News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Elisa Agostinetto: At ESMO Breast24, Hope Rugo presents results of CAPItello-291
Photo of Hope Rugo from ucsfhealth.org
May 18, 2024, 08:47

Elisa Agostinetto: At ESMO Breast24, Hope Rugo presents results of CAPItello-291

Elisa Agostinetto, Clinical Research Fellow at Institute Jules Bordet, shared a post on X/Twitter:

”At ESMO Breast24, Hope Rugo presents results of CAPItello-291: Capivasertib + fulvestrant in aromatase inhibitor-resistant HR+/HER2 – ABC showed significant increase in:

  • PFS2.
  • Time to subsequent CT.

Improvements both in the overall and PIK3CA/AKT1/PTEN altered populations.”

Elisa Agostinetto

Source: Elisa Agostinetto/X

cancer CAPItello-291 Capivasertib Elisa Agostinetto ESMO Breast24 Fulvestrant Hope Rugo OncoDaily Oncology PFS
Special Coverage
Blog
Nov 13, 2024, 09:55
Moderna Incorporation announced the awardees of its 2024 Australia Fellowship Program
Blog
Nov 13, 2024, 09:39
AI tools to improve diagnosis and therapy in neuro-oncology
Insight
Nov 13, 2024, 09:27
Nikki Rossetti et al. on Early-Stage Lung Cancer in the Era of Lung Cancer Screening
Blog
Nov 13, 2024, 09:14
Yüksel Ürün: Key takeaways on high-risk and locally advanced prostate cancer from António Rui Azevedo Freitas
Blog
Nov 13, 2024, 09:11
Clinical outcomes of early-stage triple-negative breast cancer after neoadjuvant chemotherapy
Blog
Nov 13, 2024, 09:09
Yüksel Ürün: Not all that shines is Prostate cancer – a striking reminder from Daniela Oprea-Lager
Blog
Nov 13, 2024, 09:01
Updated Results with Mitazalimab as a first-line treatment for advance pancreatic cancer
Blog
Nov 13, 2024, 08:59
Miriam Mutebi: What To Expect During A Mammogram
Insight
Nov 13, 2024, 08:56
Rachel Riechelmann: Low dose Everolimus for patients with Neuroendocrine tumors
Insight
Nov 13, 2024, 08:51
Reporting pharmacogenetic variants and cancer WGS data could guide safer prescribing
Blog
Nov 13, 2024, 08:49
Yüksel Ürün: Promising findings on SGLT2 as a biomarker for papillary RCC by Erman Akkus
Blog
Nov 13, 2024, 08:46
Karen Knudsen: Better Together - Partnering to Accelerate Progress against Cancer